
|Videos|November 19, 2020
Long-Acting Injectable Antipsychotics in the Era of COVID-19
Author(s)Frank Chen, MD
COVID-19 has made treating patients who receive long-acting injectables complicated. The Chief Medical Officer of Houston Behavioral Healthcare Hospital offers suggestions on how best to proceed.
Advertisement
The training wheels on telepsychiatry have been yanked off. Where it was once an exception, telepsychiatry is the new norm. But how does this impact the patients who need more intense care?
Frank Chen, MD, explains.
Dr Chen is Chief Medical Officer at Houston Behavioral Healthcare Hospital.
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Demystifying Artificial Intelligence: Understanding the Mechanism Behind the Magic
2
A Network-Based Approach to Depression, Neuropathic Pain, and Substance Use Disorder Using Coadministered TMS and Ketamine
3
First Patient Dose in Phase 3 Trial of AXS-14 for Treatment of Fibromyalgia
4
FDA Issues Removal of Suicidal Behavior and Ideation Warning From GLP-1 RAs
5

















